CACNA1C and glioblastoma: In summary, our experiments suggest that TTFields modulate Ca2+ signaling in two human glioblastoma cell lines which involves long-lasting activation of L-type Cav1.2 (CACNA1C) and most probably further Cav channels and which was completely suppressed by Ca2+ channel inhibitor benidipine.